Table 3.
Characteristics1 of the AOK Saxony database by psoriasis status (n=1,811,098).
| No Psoriasis (n= 1,766,475) |
Psoriasis |
P value2 | ||||
|---|---|---|---|---|---|---|
| No medication (n= 9,213) |
Exclusively topical medication (n= 31,139) |
Systemic medication (n= 4,271) |
Total (n= 44,623) |
Psoriasis vs no Psoriasis |
||
| Age (years) in 2005 | 49 (30, 68) | 57 (43, 70) | 61 (45, 72) | 54 (42, 66) | 59 (44, 71) | <1E-300 |
| Male, n(%) | 811,180 (45.9) | 4,384 (47.6) | 14,343 (46.1) | 2,020 (47.3) | 20,747 (46.5) | 0.016 |
| Hypertension, n(%)3,4 | 205,831 (19.5) | 1,063 (26.3) | 3,682 (28.9) | 580 (29.7) | 5,325 (28.4) | 1.3E-204 |
| Type 2 diabetes, n(%)3,5 | 120,507 (8.1) | 787 (11.3) | 2,860 (12.6) | 394 (12.0) | 4,041 (12.3) | 2.1E-162 |
| Myocardial infarction, n(%)3,6 | 20,103 (1.2) | 143 (1.6) | 574 (1.9) | 80 (1.9) | 797 (1.9) | 3.2E-39 |
| Peripheral arterial disease, n(%)3,7 | 31,138 (1.8) | 234 (2.7) | 918 (3.1) | 103 (2.5) | 1,255 (3.0) | 1.8E-68 |
| Angina pectoris, n(%)3,8 | 32,350 (1.9) | 251 (3.0) | 959 (3.4) | 125 (3.2) | 1,335 (3.3) | 2.4E-82 |
| Stroke, n(%)3,9 | 41,778 (2.5) | 289 (3.3) | 1,134 (3.9) | 113 (2.7) | 1,536 (3.6) | 3.8E-54 |
| Obesity, n(%)3,10 | 102,601 (6.7) | 578 (7.8) | 2,172 (8.8) | 362 (10.8) | 3,112 (8.8) | 3.0E-53 |
| Disorders of lipoprotein metabolism and other lipidaemias, n(%)3,11 |
165,526 (11.8) | 1,045 (16.7) | 3,584 (16.8) | 517 (17.1) | 5,146 (16.8) | 4.3E-158 |
| Mortality, n(%)3 | 174,642 (9.9) | 1,076 (11.7) | 4,272 (13.7) | 371 (8.7) | 5,719 (12.8) | 1.3E-92 |
1
Values are median (25th, 75th percentile) or n (percent).
2
Based on Wilcoxon-Mann-Whitney test for age and Chi-square test for categorical variables.
3
Incidence in 2007–2012.
4
n=1,075,121.
5
n=1,514,541.
6
n=1,773,833.
7
n=1,751,381.
8
n=1,715,269.
9
n=1,746,355.
10
n=1,567,015.
11
n=1,436,629.